Evaluation of Intensive Care Measures in Children with Severe New Coronavirus Infection in Pediatric Intensive Care Units

Currently, the number of publications on specific features of the clinical course and outcomes of new coronavirus infection COVID-19 in children is steadily increasing, but there are practically no works demonstrating the effectiveness of intensive care interventions, which served as the basis for the present analysis.
The objective is to assess the effectiveness of primary intensive care interventions in children with a severe course of new coronavirus infection.
Subjects and Methods. 94 patients were examined. Evaluation of intensive care measures was carried out upon admission to ICU.
Results. It was found that corticosteroids were used only in 55 (58.5%) patients (χ2 = 5.254, p = 0.022, Pearson conjugation criterion = 0.130). A moderate correlation was established between the unjustified prescription of prednisolone and the unfavorable disease outcome (χ2 = 27.98, p < 0.001, Pearson conjugation criterion = 0.296). The moderate strength of the association between the prescription of antibacterial drugs and the disease outcome was noted (χ2 = 34.01, p < 0.001, Pearson conjugation criterion = 0.331). In all lethal cases, there was volume overload due to excessive intravenous fluid administration (χ2 = 5.14, p = 0.024).
Conclusion: individual therapeutic strategies do not have a direct significant impact on outcomes of new coronavirus infection in children, however, the delivery of comprehensive intensive care presented in clinical guidelines is associated with the patient's recovery.

1. Аleksandrovich Yu.S., Аlekseeva E.I., Bakradze M.D. et al. Clinical features and management of the disease caused by new coronaviral infection (COVID-19) in children. Version 2. Pediatricheskaya Pharmocologiya, 2020, vol. 17, no. 3, pp. 187-212. (In Russ.) doi.org/10.15690/pf.v17i3.2123.

2. Аleksandrovich Yu.S., Prometnoy D.V., Mironov P.I. et al. Predictors of death in severe new coronavirus infection COVID-19 in children. Messenger of Anesthesiology and Resuscitation, 2021, vol. 18, no. 4, pp. 29-36. (In Russ.) doi. org/10.21292/2078-5658-2021-18-4-29-36.

3. Gudima G.O., Khaitov R.M., Kudlay D.А., Khaitov M.R. Molecular immunological aspects of diagnosis, prevention and treatment of coronavirus infection. Immunologiya, 2021, vol. 42, no. 3, pp. 198-210. (In Russ.) doi: https://doi.org/10.33029/0206-4952-2021-42-3-198-210.

4. Pshenisnov K.V., Аleksandrovich Yu.S., Kaziakhmedov V.А. et al. Features of current and intensive therapy of new coronavirus infection in children with comorbidities. Journal Infektologii, 2020, vol. 12, no. 3, pp. 80-89. (In Russ.) doi. org/10.22625/2072-6732-2020-12-3-80-89.

5. Ames S.G., Davis B.S., Marin J.R. et al. Emergency department pediatric readiness and mortality in critically ill children. Pediatrics, 2019, vol. 144, no. 3, pp. e20190568. doi.org:10.1542/peds.2019-0568.

6. Castagnoli R, Votto M., Licari A. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents. A systematic review. JAMA Pediatr., 2020, vol. 174, no. 9, pp. 882–889. doi. org:10.1001/jamapediatrics.2020.1467.

7. Chaudhuri D., Sasaki K., Karkar A. et al. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intens. Care Med., 2021, vol. 47, no. 5, pp. 521–537. doi.org/10.1007/s00134-021-06394-2.

8. Khateeb J., Li Y., Zhang H. Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit. Care, 2021, vol. 25, pp. 244. doi. org/10.1186/s13054-021-03662-x.

9. Kompaniyets L., Agathis N.T., Nelson J.M. et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Network Open, 2021, vol. 4, no. 6, pp. e2111182. doi.org:10.1001/jamanetworkopen.2021.11182.

10. Phua J., Weng L., Ling L. et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir. Med., 2020, vol. 8, no. 5, pp. 506–517. doi.org:10.1016/S2213-2600(20)30161-2.

11. Shekerdemian L.S., Mahmood N.R., Wolfe K.K. et al. International COVID-19 PICU Collaborative. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr., 2020, vol. 174, no. 9, pp. 868–873. doi.org:10.1001/jamapediatrics.2020.1948.

12. Tripathi S., Gist K.M., Bjornstad E.C. et al. Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Coronavirus Disease 2019-Associated PICU Admissions: A Report from the Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study Registry. Pediatr. Crit. Care, 2021, vol. 22, no. 7, pp. 603–615. doi. org:10.1097/pcc.0000000000002760.

13. Tsankov B.K., Allaire J.M., Irvine M.A. et al. Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int. J. Infect. Dis., 2021, vol. 103, pp. 246‒256. doi.org:10.1016/j.ijid.2020.11.163.

14. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne J.A.C., Murthy S. et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA, 2020, vol. 324, no. 13, pp. 1330–1341. doi. org/10.1001/jama.2020.17023.

15. World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. Interim guidance. Version 1.2, 13 March 2020. https://www.who.int/publications-detail/clinical-management-of-severeacute-respiratoryinfection-when-novel-coronavirus-(ncov)-infection-is-suspected.

16. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 2020, vol. 323, no. 13, pp. 1239–1242. htpp/doi.org:10.1001/jama.2020.2648.

17. Ye Z., Wang Y., Colunga-Lozano L.E. et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, infuenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ, 2020, vol. 192, no. 27, pp. E756–E767. https://doi.org/10.1503/cmaj.200645.